Pallidal DBS for dystonia in the age of personalized medicine

K Amande M Pauls; Joachim K Krauss; Andrea A Kühn; Elena Moro; Gereon R Fink; Jens Volkmann; Lars Timmermann

doi:10.1016/j.parkreldis.2017.09.007

Pallidal DBS for dystonia in the age of personalized medicine

Parkinsonism Relat Disord. 2017 Dec:45:101-102. doi: 10.1016/j.parkreldis.2017.09.007. Epub 2017 Sep 14.

Authors

K Amande M Pauls¹, Joachim K Krauss², Andrea A Kühn³, Elena Moro⁴, Gereon R Fink⁵, Jens Volkmann⁶, Lars Timmermann⁷

Affiliations

¹ Department of Neurology, Uniklinik Köln, Cologne, Germany. Electronic address: [email protected].
² Department of Neurosurgery, Medizinische Hochschule Hannover, Hannover, Germany.
³ Department of Neurology, Charite Universitätsmedizin Berlin, Berlin, Germany.
⁴ Division of Neurology, University Hospital Center of Grenoble, Grenoble, France.
⁵ Department of Neurology, Uniklinik Köln, Cologne, Germany; Institute of Neuroscience and Medicine (INM-3), Forschungszentrum Jülich, Jülich, Germany.
⁶ Department of Neurology, Universitätsklinikum Würzburg, Würzburg, Germany.
⁷ Department of Neurology, University of Marburg, Marburg, Germany.

PMID: 28964627
DOI: 10.1016/j.parkreldis.2017.09.007

Abstract

In response to the correspondence by Albanese and co-workers, we discuss etiology as a factor predicting outcome of pallidal DBS in dystonia, reanalysing our dataset on causes of non-response to pallidal DBS in isolated dystonia by looking only at patients with a diagnosis of idiopathic dystonia at time of surgery.

Publication types

Letter
Comment

MeSH terms

Deep Brain Stimulation*
Dystonia*
Dystonic Disorders
Globus Pallidus
Humans
Precision Medicine
Sodium-Potassium-Exchanging ATPase
Treatment Outcome

Substances

ATP1A3 protein, human
Sodium-Potassium-Exchanging ATPase

Supplementary concepts

Dystonia 12